Transcatheter aortic valve replacements alter circulating serum factors to mediate myofibroblast deactivation

The transcatheter aortic valve replacement (TAVR) procedure has emerged as a minimally invasive treatment for patients with aortic valve stenosis (AVS). However, alterations in serum factor composition and biological activity after TAVR remain unknown. Here, we quantified the systemic inflammatory e...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguado, Brian A., Schuetze, Katherine B., Grim, Joseph C., Walker, Cierra J., Cox, Anne C., Ceccato, Tova L., Tan, Aik-Choon, Sucharov, Carmen C., Leinwand, Leslie A., Taylor, Matthew R. G., McKinsey, Timothy A., Anseth, Kristi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754739/
https://www.ncbi.nlm.nih.gov/pubmed/31511425
http://dx.doi.org/10.1126/scitranslmed.aav3233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754739/
https://www.ncbi.nlm.nih.gov/pubmed/31511425
http://dx.doi.org/10.1126/scitranslmed.aav3233

Ejemplares similares